HUL - Recovery In Discretionary Portfolio; Inflation Persists: Centrum Broking
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Centrum Broking Report
We interacted with the management of Hindustan Unilever Ltd. The company indicated improvement in consumer mobility with growing vaccination and reduction in new Covid-19 cases; yet, as per Reserve Bank of India data, consumer sentiment is weak.
HUL witnessed better demand in July-August than in June.
Rural markets remain strong, with better monsoon driving kharif sowing.
While modern trade is not yet back to August 2019 levels, the general trade channel remained buoyant, driving the discretionary portfolio.
With go-to-market integration, the GlaxoSmithKline Consumer Healthcare Ltd. portfolio is picking up, backed by market interventions.
The management indicated continued inflation in palm oil and crude.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.